Jianya Zhou

机构：First People's Hospital of Yuhang District, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0001-8196-0166

发表论文 145 篇 · 总被引 2179 次 · h-index 25

代表论文

• Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial (2025 · The Lancet · 被引 33)
• First-in-class PD-1/IL-2 bispecific antibody IBI363 in patients (Pts) with advanced immunotherapy-treated non-small cell lung cancer (NSCLC). (2025 · Journal of Clinical Oncology · 被引 14)
• Immunotherapy rechallenge after ICI-related pneumonitis in lung cancer patients: a retrospective cohort study (2025 · Frontiers in Oncology · 被引 6)
• Dacomitinib in the treatment of EGFR-mutated non-small cell lung cancer with brain metastases: an open-label, multicenter, phase II study (2025 · Lung Cancer · 被引 4)
• Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype (2025 · Journal of Translational Medicine · 被引 3)
• Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study (2025 · Journal of Thoracic Oncology · 被引 2)